Top Markets
#1 MowCat MowCat +779.42%
#2 龙虾 (Lobster) 龙虾 (Lobster) +86.88%
#3 Akedo Akedo +53.14%
#4 Magma Finance Magma Finance +43.48%
#5 SIXSEVEN SIXSEVEN +30.64%
#6 DeXe DeXe +29.84%
#7 MarsCoin MarsCoin +29.20%
#8 Cortex Cortex +26.39%
#9 Pons Pons +15.85%
#10 Nillion Nillion +13.67%
Coin of the day
MowCat MowCat
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
Rang in Aktien #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
Aktienkurs
$25.61
Zuletzt synchronisiert: 2025-10-10
Marktkapitalisierung
$1.37B
Veränderung (1 Tag)
0.20%
Veränderung (1 Jahr)
1.59%
Land
US
Handel Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

Kategorie

Healthcare
Dividendenhistorie für Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
Harrow Health, Inc. 8.625% Senior Notes due 2026 (Aktienkürzel: HROWL) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Dividendenzahlungen Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
23.00%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
0.00%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
0.00%
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
69.00%
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
0.00%
IT